Evercore stock dips after earnings and revenue fall short of analyst views, but the bank is hiring
Evercore Inc. (EVR) stock was down 3% in pre-market trading on Wednesday after the investment bank's second-quarter profit and revenue fell short of estimates, while the bank said it hired more senior managing directors in anticipation of an increase in deal-making. Evercore said its profit for the three months ended June 30 dropped by 61% to $37.21 million, or 95 cents a share, from $95.63 million, or $2.33 a share, in the year-ago quarter. Evercore was expected to earn $1.26 a share, according to FactSet research. Revenue at Evercore dropped to $503.6 million from $635.18 million, below the analyst target of $512.9 million. Evercore said seven advisory senior managing directors joined the firm during the quarter, and an additional six advisory senior managing directors committed to work at the bank. "It has been an extraordinary time to recruit exceptional talent and we are proud of our hiring success so far this year, positioning the firm for when the market recovers," said Evercore CEO John S. Weinberg. Senior chairman Robert Altman said the firm has done more external hiring in 2023 at the senior managing director level than any time in the bank's history.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-26-23 0756ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?